Mylan Pharmaceuticals

Activities: Drug Delivery Pharmaceutical

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Finance

Mylan chooses Beximco for exclusive antibody distribution in Bangladesh

Beximco Pharma has received the exclusive rights to launch Netherlands-based Mylan’s portfolio of key monoclonal antibodies in its headquarters of Bangladesh
Regulatory

Biocon biologics facility gets FDA nod

India's biopharmaceutical giant has been investing in expanding manufacturing capacity in line with expectations of higher biosimilars penetration in developed and emerging market
Finance

Pfizer and Mylan to launch new global pharmaceutical company

Upjohn, Pfizer’s off-patent branded and generic business, will merge with Mylan
Drug Delivery

Mylan and Hospira voluntarily recall injectables

Glass and copper salts were found in the companies’ injectable medications but no adverse reactions have been reported as yet
Media

Global market for inhaled drugs rapidly growing

As incidences of diseases such as COPD and asthma rise, so too does the global demand for inhaled drugs, especially those using innovative new delivery technologies
Research & Development

Mylan to acquire Renaissance's speciality and generic topical business

Mylan is acquiring the business on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash and available borrowings under existing credit facilities
Regulatory

Delhi High Court puts restrictions on Biocon and Mylan breast cancer drug marketing

Court allowed the sale and manufacture of affordable cancer drugs by Biocon and Mylan with certain restrictions on packaging and labelling and regulatory process
Subscribe now